Factor VIIa-Antithrombin complexes as a measure of tissue factor activity in patients with antiphospholipid antibodies: A potential biomarker for thrombotic risk.

被引：0
|
作者：
Lovell, Tracy
Morrissey, James H.
Roubey, Robert A. S.
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Univ Illinois, Urbana, IL 61801 USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S555 / S555
页数：1
相关论文
共 50 条
  • [21] Factor VIIA/antithrombin complexes in cirrhotics with and without portal vein thrombosis: a possibly marker of increased thrombotic risk?
    Rossetto, V
    Spiezia, L.
    Gavasso, S.
    Fadin, M.
    Campello, E.
    Sartori, M. T.
    Senzolo, M.
    Rodriguez, K.
    Woodhams, B.
    Simioni, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 805 - 805
  • [22] Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura
    Habe, Koji
    Wada, Hideo
    Matsumoto, Takeshi
    Ohishi, Kohshi
    Ikejiri, Makoto
    Matsubara, Kimiko
    Morioka, Tatsuhiko
    Kamimoto, Yuki
    Ikeda, Tomoaki
    Katayama, Naoyuki
    Mizutani, Hitoshi
    INTERNAL MEDICINE, 2016, 55 (06) : 589 - 595
  • [23] MECHANISM OF ANTITHROMBIN-III INHIBITION OF FACTOR VIIA TISSUE FACTOR ACTIVITY ON CELL-SURFACES - COMPARISON WITH TISSUE FACTOR PATHWAY INHIBITOR FACTOR XA-INDUCED INHIBITION OF FACTOR VIIA TISSUE FACTOR ACTIVITY
    RAO, LVM
    NORDFANG, O
    HOANG, AD
    PENDURTHI, UR
    BLOOD, 1995, 85 (01) : 121 - 129
  • [24] The effect of cell surface glycosaminoglycans (GAGs) on the inactivation of factor VIIa tissue factor activity by antithrombin III
    Hamamoto, T
    Kisiel, W
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1998, 68 (01) : 67 - 78
  • [25] Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies
    Seshan, Surya V.
    Franzke, Claus-Werner
    Redecha, Patricia
    Monestier, Marc
    Mackman, Nigel
    Girardi, Guillermina
    BLOOD, 2009, 114 (08) : 1675 - 1683
  • [26] THROMBOCYTOPENIA IS A THROMBOTIC RISK FACTOR IN PATIENTS WITH POSITIVE ANTIPHOSPHOLIPID ANTIBODIES WITHOUT CLINICAL CRITERIA OF THE DISEASE?
    Demetrio Pablo, R.
    Munoz, P.
    Calvo-Rio, V.
    Riancho-Zarrabeitia, L.
    Lopez-Hoyos, M.
    Martinez-Taboada, V. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 779 - 779
  • [27] PLASMA FACTOR VIIA-ANTITHROMBIN COMPLEXES LEVELS IN ACUTE ISCHEMIC STROKE ARE NOT ASSOCIATED WITH C-REACTIVE PROTEIN AND STROKE SEVERITY
    Zekanowska, E.
    Slomka, A.
    Switonska, M.
    Sinkiewicz, W.
    Rosc, D.
    THROMBOSIS RESEARCH, 2016, 141 : S38 - S38
  • [28] Plasma Microparticle Tissue Factor Activity in Patients With Antiphospholipid Antibodies With and Without Clinical Complications
    Willemze, Rose
    Bradford, Robert L.
    Mooberry, Micah J.
    Roubey, Robert A. S.
    Key, Nigel S.
    THROMBOSIS RESEARCH, 2014, 133 (02) : 187 - 189
  • [29] Factor XII antibodies in patients with phospholipid antibodies: Are they predictors of thrombotic risk?
    Jones, DW
    Joseph, JE
    Donohoe, S
    Mackie, IJ
    Gallimore, MJ
    Winter, M
    THROMBOSIS AND HAEMOSTASIS, 1999, : 66 - 67
  • [30] Antiphospholipid antibodies in patients with dysglycaemia: A neglected cardiovascular risk factor?
    Ferrannini, Giulia
    Svenungsson, Elisabet
    Kjellstrom, Barbro
    Elvin, Kerstin
    Grosso, Giorgia
    Nasman, Per
    Ryden, Lars
    Norhammar, Anna
    DIABETES & VASCULAR DISEASE RESEARCH, 2020, 17 (03):
12345